Home PR Newswire
Friday, May 9, 2025
30.4
C
Bengaluru
My account
Get into your account.
Hot topics
National Seminar on UCPMP
The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME's, sampling, gifts etc.
3 Rules of the Digital World for Pharma Brand Managers
The first time I heard the term ‘digital economy’...
Digital Darwinism or Digital Expert – The Choice for Indian Pharma is Clear
It is heartening to see that Pharma marketers have...
Rethinking Healthcare Communications for the Indian Context
Indian healthcare is sometimes an enigma: on one hand...
Indian Pharma Market October 2021 – IQVIA Report
IPM was valued at Rs. 178,219 Cr for MAT Oct’21. The retail sector was valued at Rs. 151,183 Cr for this period contributing 85% to IPM.
IPM Growth for the month of Oct’21 as compared to the month of Oct’20 was 9.7%. This is the lowest monthly growth in the last 8 months after a low growth of 2.6% reported for Feb’21.
Corresponding to low monthly growth, IPM MAT growth also declined slightly after showing a growing trend consistently for the last 7 months from MAT Feb’21. It reported 17.3% for MAT Oct’21 as compared to 17.8% reported for MAT Sept’21.
At 15657.3 Cr, the monthly sale reported for Oct’21 is the 5th highest sale value in the last 12 months.
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Hot topics
Why Pharma Sales Enablement Is a Necessity for Success
Challenging times lay ahead for the sales departments in the pharma industry. The COVID-19 pandemic will surely not be the first disruption, as recent geopolitical tensions, and economic turmoil show. Agile and adaptive sales enablement is thus a must-have in the coming months and years.
First Approach in Pharma
Independence Day Special issue with Vivek Hattangadi tracing the India pharma brand story from before Independence till today.
Dr. Tarun Gupta Tribute Issue
Editor's Note - This issue of MedicinMan is dedicated to the memory of Dr. Tarun Gupta, TG as he was fondly called. Executive Editor, Salil Kallianpur, dear friend Subrato Banerjee and long-time MedicinMan patron Vivek Hattangadi, pen their tributes to TG.
7 Transitions in Leadership for Indian Pharma Leaders
The rapid pace of change, which began in 2020...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
Newsletter
Get important news delivered directly to your inbox and stay connected!